GliaPharm is a Swiss biotechnology company developing treatments for orphan neurological disorders. The company has developed a proprietary platform and pipeline of molecules targeting brain glial cells to restore brain metabolism deficits in orphan diseases linked to brain metabolism dysfunction.


Chemin des Mines 9, Geneva, Switzerland

Facts & figures
  • Type of organization

    Private company

  • Year of foundation


  • Number of employees in Switzerland


Key business